comparison the effect of two kind of HCG in IVF cycle

comparison the effect of Recombinant HCG and urinary HCG in infertile women at IVF cycle

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201107034339N2

Enrollment

200

Registered

2011-08-09

Start date

2009-01-01

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female infertility. ???????? ????

Interventions

Intervention 1: Intervention group: Patients undergo pituitary desensitization with Decapeptyl 0.1 mg/day (Decapeptyl® 0.1 mg, Ferring, Germany)starting in the mid luteal phase and was continue

Eligibility

Sex/Gender

Female

Age

No minimum to 38 Years

Inclusion criteria

Inclusion criteria: regular menstrual cycles age<38 years old FSH<10 IU/L BMI<30kg/m2

Exclusion criteria

Exclusion criteria: history of metabolic or endocrine disorder history of pelvic surgery severe male factor infertilitywhich was defined as severe oligospermia (<5million sperm/ml),asthenospermia (5% progressive motility),or teratospermia (4% normal forms by strict criteria).

Design outcomes

Primary

Measure	Time frame
Number and maturity of oocyte. Timepoint: ovum pick up. Method of measurement: by microscope.	—

Secondary

Measure	Time frame
Chemical pregnancy. Timepoint: 14 days after embryo transfer. Method of measurement: blood.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Maryam Eftekhar

Yazd University of Medical Sciences

eftekhar@ssu.ac.ir+98 35 1824 7085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026